Sticky Steroids: In Search of an Approved Treatment for Eosinophilic Esophagitis.
暂无分享,去创建一个
[1] P. Mitchell,et al. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet , 2017, Journal of pediatric gastroenterology and nutrition.
[2] S. Cucchiara,et al. A New Formulation of Oral Viscous Budesonide in Treating Paediatric Eosinophilic Oesophagitis: A Pilot Study , 2017, Journal of pediatric gastroenterology and nutrition.
[3] I. Hill. Role of Biopsies in Childhood Celiac Disease: Do We Need Less or More? , 2017, Journal of pediatric gastroenterology and nutrition.
[4] A. Muir,et al. Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children. , 2016, The journal of allergy and clinical immunology. In practice.
[5] A. Bredenoord,et al. Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity , 2015, The American Journal of Gastroenterology.
[6] Lisa J. Martin,et al. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. , 2015, The Journal of allergy and clinical immunology.
[7] Sandeep K. Gupta,et al. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] M. Zwahlen,et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. , 2014, Gastroenterology.
[9] Douglas R. McDonald,et al. Comparison of 2 Delivery Vehicles for Viscous Budesonide to Treat Eosinophilic Esophagitis in Children , 2014, Journal of pediatric gastroenterology and nutrition.
[10] J. Pandolfino,et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] A. Pariser,et al. Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases. , 2012, The Journal of allergy and clinical immunology.
[12] Yukako Yagi,et al. Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens. , 2011, Gastrointestinal endoscopy.
[13] A. Schoepfer,et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. , 2011, The Journal of allergy and clinical immunology.
[14] A. Schoepfer,et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. , 2010, Gastroenterology.
[15] S. Aceves,et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. , 2010, Gastroenterology.
[16] M. Collins,et al. Dissociation Between Symptoms and Histological Severity in Pediatric Eosinophilic Esophagitis , 2009, Journal of pediatric gastroenterology and nutrition.
[17] S. Aceves,et al. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. , 2005, The Journal of allergy and clinical immunology.
[18] L. Burgart,et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. , 1998, Journal of pediatric gastroenterology and nutrition.